Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A thorough medical assessment is recommended
Compounded Semaglutide for Patients With PCOS and Weight or Insulin-Resistance Concerns Highland Longevity prescribes compounded semaglutide not Wegovy or Ozempic
Change is possible, and you dont have to do it alone
These drugs, originally approved for type 2 diabetes, lower A1c, slow digestion to increase satiety, increase fat utilization, and have led to dramatic weight loss results of around 12%17% of body weight after 48 weeks of use
With the implicit validity of these data given the expected weight regain seen after therapy cessation, there is some credence to the idea that this is a genuine reflection of nondurability of weight loss with GLP-1 receptor agonist therapy
Top-line outcomes: STEP 4 maintenance data is particularly relevant for researchers modelling discontinuation effects: participants who stopped Semaglutide regained approximately two-thirds of lost weight within 1 year, while those continuing maintained their loss, supporting the hypothesis that chronic GLP-1R engagement is required for sustained metabolic effects
US$ 26.95
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 26.72
US$ 27.59
,type=downsize)
